RLAY
Relay Therapeutics Inc
17.70$
-1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.9% | -0.3% | -8.2% | +20.4% | -6.3% | -8.3% | -8.8% | -8.1% | -7.3% | +12.6% | +38.3% | |
| – | -7.4% | 0.0% | -8.5% | +22.8% | -6.5% | -8.6% | -8.0% | -8.3% | -7.3% | +13.9% | +40.9% | |
| – | -5.0% | +6.4% | -12.3% | +13.6% | -18.4% | -24.7% | +21.8% | -19.6% | -8.2% | +143.5% | -40.8% | |
| – | -7.5% | -0.1% | -8.2% | +22.0% | -6.9% | -9.1% | -7.5% | -9.2% | -7.0% | +15.8% | +41.9% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | |
| – | -28.5% | +4.0% | -5.1% | +0.5% | +2.5% | -16.3% | -19.3% | -1.4% | -12.9% | +5.8% | +34.9% | |
| – | -40.4% | +22.7% | +21.3% | +4.3% | +8.0% | -27.0% | -12.2% | +0.2% | -21.6% | +16.3% | +70.8% | |
| – | +3.7% | +3.7% | +3.7% | +3.6% | +3.6% | +3.5% | -40.6% | +3.3% | +3.3% | +3.3% | +3.2% | |
| – | -31.0% | -13.4% | +40.1% | -38.5% | +105.3% | -40.1% | -38.7% | -46.8% | +180.0% | -46.7% | +179.2% | |
| – | -3.4% | -0.8% | -8.6% | +23.0% | -7.3% | -7.3% | -7.7% | -8.7% | -6.7% | +13.2% | +38.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +6.7% | +1.5% | +5.6% | +19.3% | +1.1% | +1.2% | +0.7% | -0.5% | +4.8% | +12.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.